Some efficacy trials show that curcumin can be delivered to colorectal cancer cells via aptamer-functionalized PLGA-lecithin-PEG nanoparticles (Apt-CUR-NPs).69 In Apt-CUR-NPs strategy, RNA aptamer specifically targets EpCAM protein in colorectal cancer cell. Here, EPCAM is linked to colorectal cancer.